Niemann Isa, Sunde Lone, Petersen Lone K
Department of Clinical Genetics, University Hospital of Aarhus, Aarhus, Denmark.
Am J Obstet Gynecol. 2007 Jul;197(1):45.e1-5. doi: 10.1016/j.ajog.2007.02.038.
This study was undertaken to evaluate the risk of persistent trophoblastic disease and obstetric complications related to a multiple pregnancy comprising a diploid hydatidiform mole and normal cofetus(es).
From a database of 270 consecutively collected hydatidiform moles, 8 multiple and 154 singleton molar pregnancies were identified. Molar and fetal ploidy was determined, and data on clinical features and chemotherapy were collected. Differences between groups were assessed with Fisher's exact or Mann-Whitney test.
The molar component in all 8 multiple pregnancies was diploid. Five patients with diploid mole and coexisting fetus pregnancy chose to terminate their pregnancy, 2 aborted spontaneously, and 1 patient delivered a healthy child. Two diploid mole and coexisting fetus pregnancies (25%) and 17% of the singleton molar pregnancies were followed by persistent trophoblastic disease (P = .63).
The risk of persistent trophoblastic disease after a diploid mole with coexisting fetus pregnancy is similar to that after a singleton molar pregnancy, and expectant management instead of therapeutic abortion can be pursued.
本研究旨在评估与包含二倍体葡萄胎和正常胎儿的多胎妊娠相关的持续性滋养细胞疾病风险及产科并发症。
从连续收集的270例葡萄胎数据库中,识别出8例多胎和154例单胎葡萄胎妊娠。确定了葡萄胎和胎儿的倍体,并收集了临床特征和化疗数据。组间差异采用Fisher精确检验或Mann-Whitney检验进行评估。
所有8例多胎妊娠中的葡萄胎成分均为二倍体。5例二倍体葡萄胎合并胎儿妊娠患者选择终止妊娠,2例自然流产,1例患者分娩出一名健康婴儿。2例二倍体葡萄胎合并胎儿妊娠(25%)和17%的单胎葡萄胎妊娠后发生持续性滋养细胞疾病(P = 0.63)。
二倍体葡萄胎合并胎儿妊娠后发生持续性滋养细胞疾病的风险与单胎葡萄胎妊娠后相似,可采用期待治疗而非治疗性流产。